Please ensure Javascript is enabled for purposes of website accessibility
REVIEW PAPER
The influence of salt iodisation on the incidence of thyroid cancer
 
More details
Hide details
1
Student Scientific Society at Department of Endocrinology and Neuroendocrine Tumors, Chair of Pathophysiology and Endocrinology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland
 
2
Department of Endocrinology and Neuroendocrine Tumors, Chair of Pathophysiology and Endocrinology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland
 
 
Submission date: 2024-01-24
 
 
Final revision date: 2024-06-05
 
 
Acceptance date: 2024-06-24
 
 
Publication date: 2024-09-13
 
 
Corresponding author
Karolina P. Sas
Student Scientific Society at Department of Endocrinology and Neuroendocrine Tumors, Chair of Pathophysiology and Endocrinology, Faculty of Medical Sciences, Zabrze, Poland
 
 
Medical Studies 2024;40(4):394-397
 
KEYWORDS
TOPICS
ABSTRACT
The article analyses the relationship between iodine deficiency, the occurrence of thyroid cancer, and the effectiveness of salt iodisation. Iodine deficiency affects a large number of people around the world, including Poland, where both moderate iodine deficiency and an increase in the incidence of thyroid cancer are observed. The positive effect of salt iodisation on reducing thyroid goitre is noticeable. Additionally, the analysis shows a correlation between the BRAF mutation and an increase in the incidence of papillary cancer, especially in areas with excessive iodine intake. However, it is worth noting that proper iodine intake is associated with a decrease in follicular cancer. The increase in thyroid cancer cases is related to widespread ultrasonography, environmental pollution, diet, as well as recommendations to limit salt intake due to society’s cardiological problems. A constant level of iodine in the body contributes to reducing the malignancy of thyroid cancer, confirming the importance of salt iodisation.
REFERENCES (29)
1.
Universal Salt Iodization and Sodium Intake Reduction: Compatible, Cost–effective Strategies of Great Public Health Benefit. World Health Organization; 2022.
 
2.
Pearce EN, Zimmermann MB. The prevention of iodine deficiency: a history. Thyroid. 2023; 33(2): 143-149.
 
3.
 
4.
Gérard AC, Poncin S, Caetano B. Iodine deficiency induces a thyroid stimulating hormone-independent early phase of microvascular reshaping in the thyroid. Am J Pathol. 2008; 172(3): 748-760.
 
5.
Program for eliminating iodine deficiency in Poland for 2012-2016, Ministry of Health of the Republic of Poland, Warsaw 2012.
 
7.
Robertson A, Tirado C, Lobstein T, Jermini M, Knai C, Jensen JH, Ferro-Luzzi A, James WP. Food and health in Europe: a new basis for action. WHO Reg Publ Eur Ser. 2004; (96): i-xvi, 1-385.
 
8.
Trofimiuk-Müldner M, Konopka J, Sokołowski G, Du- biel A, Kieć-Klimczak M, Kluczyński Ł, Motyka M, Rzepka E, Walczyk J , Sokołowska M, Buziak-Bereza M, Tisończyk J, Pach D, Hubalewska-Dydejczyk A. Current iodine nutrition status in Poland (2017): is the Polish model of obligatory iodine prophylaxis able to eliminate iodine deficiency in the population? Public Health Nutrition. 2020; 23 (14): 2467-2477.
 
9.
Szybiński Z, Zarnecki A. Prevalence of goiter, iodine deficiency and iodine prophylaxis in Poland. The results of a nationwide study. Endokrynol Pol. 1993; 44(3): 373-388.
 
10.
Szybiński Z; Polish Council for Control of Iodine Deficiency Disorders. Work of the Polish Council for Control of Iodine Deficiency Disorders, and the model of iodine prophylaxis in Poland. Endokrynol Pol. 2012; 63(2): 156-160.
 
11.
Szybiński Z, Huszno B, Zemla B. Incidence of thyroid cancer in the selected areas of iodine deficiency in Poland. J Endocrinol Invest. 2003; 26(2 Suppl): 63-70.
 
12.
Lewiński A, Szybiński Z, Bandurska-Stankiewicz E. Iodine-induced hyperthyroidism-an epidemiological survey several years after institution of iodine prophylaxis in Poland. J Endocrinol Invest. 2003; 26(2 Suppl): 57-62.
 
13.
Szybiński Z. Iodine prophylaxis in Poland in light of the WHO recommendation on reduction of the daily salt intake. Pediatr Endocrinol Diabetes Metab. 2009; 15(2): 103-107.
 
14.
Knobel M, Medeiros-Neto G. Relevance of iodine intake as a reputed predisposing factor for thyroid cancer. Arq Bras Endocrinol Metabol. 2007 Jul; 51(5): 701-712.
 
15.
Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med. 1998 Jan 29; 338(5): 297-306.
 
16.
Ward MH, Kilfoy BA, Weyer PJ. Nitrate intake and the risk of thyroid cancer and thyroid disease. Epidemiology. 2010 May; 21(3): 389-395.
 
17.
Kermoison G, Draganescu C. Role of dietary and environmental factors on thyroid cancer in Romania: a brief review. Diagnostics (Basel). 2022 Aug 13; 12(8): 1959.
 
18.
Bartholomeusz C, Gonzalez-Angulo AM. Targeting the PI3K signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012 Jan; 16(1): 121-130.
 
19.
Kilfoy BA, Zhang Y, Park Y. Dietary nitrate and nitrite and the risk of thyroid cancer in the NIH-AARP Diet and Health Study. Int J Cancer. 2011 Jul; 129(1): 160-172.
 
20.
Gaberšček S, Zaletel K. Epidemiological trends of iodine-related thyroid disorders: an example from Slovenia. Arh Hig Rada Toksikol. 2016 Jun; 67(2): 93-98.
 
21.
Zaletel K, Gaberscek S, Pirnat E. Ten-year follow-up of thyroid epidemiology in Slovenia after increase in salt iodization. Croat Med J. 2011 Oct; 52(5): 615-621.
 
22.
Besic N, Gazic B. Dietary iodine intake, therapy with radioiodine, and anaplastic thyroid carcinoma. Radiol Oncol. 2020 May; 54(2): 187-193.
 
23.
Harach HR, Galíndez M, Campero M. Undifferentiated (anaplastic) thyroid carcinoma and iodine intake in Salta, Argentina. Endocr Pathol. 2013 Sep; 24(3): 125-131.
 
24.
Zivaljevic V, Slijepcevic N, Paunovic I. Risk factors for anaplastic thyroid cancer. Int J Endocrinol. 2014; 2014: 815070.
 
25.
McIver B, Hay ID, Giuffrida DF. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery. 2001 Dec; 130(6): 1028-1034.
 
26.
Zimmermann MB. Iodine deficiency. Endocr Rev. 2009 Jun; 30(4): 376-408.
 
27.
Feldt-Rasmussen U. Iodine and cancer. Thyroid. 2001 May; 11(5): 483-486.
 
28.
Zimmermann MB, Galetti V. Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies. Thyroid Res. 2015 Jun; 8: 8.
 
29.
Andersson M, Karumbunathan V, Zimmermann MB. Global iodine status in 2011 and trends over the past decade. J Nutr. 2012 Apr; 142(4): 744-750.
 
eISSN:2300-6722
ISSN:1899-1874
Journals System - logo
Scroll to top